BCMAS EXAM AND STUDY GUIDE NEWEST 2025 TEST
BANK| COMPLETE 650 REAL EXAM QUESTIONS AND
CORRECT DETAILED ANSWERS (VERIFIED ANSWERS)
ALREADY GRADED A+| BCMAS FINAL EXAM PREP
2025 (BRAND NEW!!)
Most commonly used study design: .....ANSWER..... parallel
Under what conditions can a pharma company provide financial
support for conferences and CME? .....ANSWER..... The
grants/contributions are separate from other company funds
The company has had no control over the selection of content,
faculty, or venue
Not required by ADR reporting: .....ANSWER..... careful selection
of clinical trial participants
,Required:
-recognition of events
-safety signals are identified against a background of events
-accurate reporting
Individual board members are known as: .....ANSWER..... advisors
in vitro diagnostic test - example .....ANSWER..... microbiology
culture
in vitro versus in vivo .....ANSWER..... in vitro describes something
"in glass" such as a test tube or petri dish
in vivo is "within a living organism"
Fundamental requirement for ongoing risk evaluations of REMS:
.....ANSWER..... timely data collection
,Best practice and ethical standards for reporting research
published in medical journals .....ANSWER..... ICMJE
T/F: Elements to Assure Safe Use (ETASU) are required medical
interventions taken by HCPs prior to using the drug.
.....ANSWER..... True
Combination product applicant(s) .....ANSWER..... The company
that holds the application for the combination product as a whole
T/F: Severe birth defects is not an FDA mandated REMS.
.....ANSWER..... False
Export challenge of a medical device company: .....ANSWER.....
Violation of intellectual property rights
Purposes of IIS .....ANSWER..... develop and support new
indication
enhance pt benefits/health outcomes
improve available product safety and
, NOT a purpose = support pt community
Goals of pharmacogenomics .....ANSWER..... Individualize
therapies based on genetic differences
Predict individual responses to a drug to decrease adverse drug
reactions
Improve the overall efficacy and safety of drugs
NOT a goal = decrease medication adherence
FDA clearance for medical devices .....ANSWER..... May be given
for devices with substantial equivalence to a known predicate
device
Allows the device to be marketed and sold once a Pre-Market
Notification has been submitted
BANK| COMPLETE 650 REAL EXAM QUESTIONS AND
CORRECT DETAILED ANSWERS (VERIFIED ANSWERS)
ALREADY GRADED A+| BCMAS FINAL EXAM PREP
2025 (BRAND NEW!!)
Most commonly used study design: .....ANSWER..... parallel
Under what conditions can a pharma company provide financial
support for conferences and CME? .....ANSWER..... The
grants/contributions are separate from other company funds
The company has had no control over the selection of content,
faculty, or venue
Not required by ADR reporting: .....ANSWER..... careful selection
of clinical trial participants
,Required:
-recognition of events
-safety signals are identified against a background of events
-accurate reporting
Individual board members are known as: .....ANSWER..... advisors
in vitro diagnostic test - example .....ANSWER..... microbiology
culture
in vitro versus in vivo .....ANSWER..... in vitro describes something
"in glass" such as a test tube or petri dish
in vivo is "within a living organism"
Fundamental requirement for ongoing risk evaluations of REMS:
.....ANSWER..... timely data collection
,Best practice and ethical standards for reporting research
published in medical journals .....ANSWER..... ICMJE
T/F: Elements to Assure Safe Use (ETASU) are required medical
interventions taken by HCPs prior to using the drug.
.....ANSWER..... True
Combination product applicant(s) .....ANSWER..... The company
that holds the application for the combination product as a whole
T/F: Severe birth defects is not an FDA mandated REMS.
.....ANSWER..... False
Export challenge of a medical device company: .....ANSWER.....
Violation of intellectual property rights
Purposes of IIS .....ANSWER..... develop and support new
indication
enhance pt benefits/health outcomes
improve available product safety and
, NOT a purpose = support pt community
Goals of pharmacogenomics .....ANSWER..... Individualize
therapies based on genetic differences
Predict individual responses to a drug to decrease adverse drug
reactions
Improve the overall efficacy and safety of drugs
NOT a goal = decrease medication adherence
FDA clearance for medical devices .....ANSWER..... May be given
for devices with substantial equivalence to a known predicate
device
Allows the device to be marketed and sold once a Pre-Market
Notification has been submitted
